Summary of Product Characteristics
last updated on the eMC:
24/04/2012
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 24/04/2012 and displayed until Current
|
Reasons for adding or updating:
|
-
Change of Marketing Authorisation Holder
|
| Date of revision of text on the SPC: 06-Apr-2012 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
Please note changes highlighted in red below:
7. MARKETING AUTHORISATION HOLDER
Alliance Pharmaceuticals Ltd
Avonbridge House
Bath Road
Chippenham
Wiltshire
SN15 2BB
UK
8. MARKETING AUTHORISATION NUMBER(S)
PL 16853/0134
|
|
Updated on 16/01/2012 and displayed until 24/04/2012
|
Reasons for adding or updating:
|
-
Change to section 5.1 - Pharmacodynamic Properties
-
Change to section 5.2 - Pharmacokinetic Properties
-
Change to section 10 date of revision of the text
-
Correction of spelling/typing errors
|
| Date of revision of text on the SPC: 27-Oct-2010 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Sections 5.1 and 5.2 - updated information in relation to paediatrics
|
|
Updated on 08/08/2011 and displayed until 16/01/2012
|
Reasons for adding or updating:
|
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 08-Jun-2009 |
| Legal Category: POM |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Section 10 - renewal date 08/06/2009
|
|
Updated on 07/07/2006 and displayed until 08/08/2011
|
Reasons for adding or updating:
|
|
|
|